年単位の研究成果
Fingerprint Naoya Sawamuraが取り組む研究トピックをご確認ください。これらのトピックラベルは、この人物の研究に基づいています。これらを共に使用することで、固有の認識が可能になります。
Amyloidogenic Proteins
Medicine & Life Sciences
Serum Amyloid A Protein
Medicine & Life Sciences
Alzheimer Disease
Medicine & Life Sciences
Brain
Chemical Compounds
Schizophrenia
Medicine & Life Sciences
Amyloid Plaques
Medicine & Life Sciences
Cholesterol
Medicine & Life Sciences
Ubiquitin-Protein Ligases
Medicine & Life Sciences
ネットワーク
最近の共同研究。丸をクリックして詳細を確認しましょう。
研究成果 1994 2019
Data for positive selection test and co-evolutionary analysis on mammalian cereblon
Onodera, W., Asahi, T. & Sawamura, N., 2019 10 1, ： : Data in Brief. 26, 104499.研究成果: Article
公開
Ubiquitin-Protein Ligases
AMP-Activated Protein Kinases
Proteins
Sequence Alignment
Ubiquitination
1
引用
(Scopus)
Positive selection of cereblon modified function including its E3 ubiquitin ligase activity and binding efficiency with AMPK
Onodera, W., Asahi, T. & Sawamura, N., 2019 6 1, ： : Molecular Phylogenetics and Evolution. 135, p. 78-85 8 p.研究成果: Article
AMP-activated protein kinase
ubiquitin-protein ligase
AMP-Activated Protein Kinases
Ubiquitin-Protein Ligases
Molecular Evolution
5
引用
(Scopus)
Antioxidant activity of Ge-132, a synthetic organic germanium, on cultured mammalian cells
Wada, T., Hanyu, T., Nozaki, K., Kataoka, K., Kawatani, T., Asahi, T. & Sawamura, N., 2018 1 1, ： : Biological and Pharmaceutical Bulletin. 41, 5, p. 749-753 5 p.研究成果: Article
Germanium
Cultured Cells
Antioxidants
Hydrogen Peroxide
Reactive Oxygen Species
Cholinergic receptor, nicotinic, alpha 7 as a target molecule of Arctic mutant amyloid β
Sawamura, N., Ju, Y. & Asahi, T., 2018 8 1, ： : Neural Regeneration Research. 13, 8, p. 1360-1361 2 p.研究成果: Short survey
Amyloid
Mouse Chrna7 protein
4
引用
(Scopus)
The Neuroprotective Effect of Thalidomide against Ischemia through the Cereblon-mediated Repression of AMPK Activity
Sawamura, N., Yamada, M., Fujiwara, M., Yamada, H., Hayashi, H., Takagi, N. & Asahi, T., 2018 12 1, ： : Scientific Reports. 8, 1, 2459.研究成果: Article
AMP-Activated Protein Kinases
Thalidomide
Neuroprotective Agents
Ischemia
Middle Cerebral Artery Infarction